KNW: Know Labs Inc Price to Sales

Know Labs, Inc. (KNW) develops innovative RF sensors for non-invasive glucose monitoring using proprietary Bio-RFID technologies. The estimated P/S ratio reflects the company's current market valuation, where 5978.50 describes the current status of the metric. An environmental development vector minimizes plastic waste, while the pristine condition of production facilities and equipment calibration ensure the stable output of biosensors.
Analytical breakdowns for Know Labs Corp (KNW)

The development of non-invasive glucose monitoring systems for diabetics determines the future cash flows of Know Labs, Inc. (KNW) via insurance payouts. The ratio of market capitalization to sales, represented by the company's average P/S, measures the current business value relative to revenue, where an inflated multiple signals a risk of asset impairment when compared to historical trends.